Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_assertion type Assertion NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_head.
- NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_assertion wasGeneratedBy ECO_0000203 NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_provenance.
- NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_assertion wasDerivedFrom befree-20150227 NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_provenance.
- NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_assertion SIO_000772 16609019 NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_provenance.
- NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_assertion evidence source_evidence_literature NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_provenance.
- NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_assertion description "[We examined the association between the ratio of the homeobox 13 (HOXB13) to interleukin-17B receptor (IL-17BR) expression and the clinical outcomes of relapse and survival in women with ER-positive breast cancer enrolled onto a North Central Cancer Treatment Group adjuvant tamoxifen trial (NCCTG 89-30-52).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919039.RA010QnLsGO7HnpL8Mnk80GZzjeDYZ0HD5B99yXb25g0E130_provenance.